IBDEI0KX ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10255,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,10256,0)
 ;;=682.1^^67^673^9
 ;;^UTILITY(U,$J,358.3,10256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10256,1,4,0)
 ;;=4^682.1
 ;;^UTILITY(U,$J,358.3,10256,1,5,0)
 ;;=5^Cellulitis Of Neck
 ;;^UTILITY(U,$J,358.3,10256,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,10257,0)
 ;;=376.01^^67^673^10
 ;;^UTILITY(U,$J,358.3,10257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10257,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,10257,1,5,0)
 ;;=5^Cellulitis Of Orbit
 ;;^UTILITY(U,$J,358.3,10257,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,10258,0)
 ;;=681.10^^67^673^11
 ;;^UTILITY(U,$J,358.3,10258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10258,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,10258,1,5,0)
 ;;=5^Cellulitis Of Toe
 ;;^UTILITY(U,$J,358.3,10258,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,10259,0)
 ;;=682.2^^67^673^12
 ;;^UTILITY(U,$J,358.3,10259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10259,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,10259,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,10259,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,10260,0)
 ;;=070.1^^67^673^26
 ;;^UTILITY(U,$J,358.3,10260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10260,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,10260,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,10260,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,10261,0)
 ;;=070.30^^67^673^27
 ;;^UTILITY(U,$J,358.3,10261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10261,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,10261,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,10261,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,10262,0)
 ;;=070.32^^67^673^28
 ;;^UTILITY(U,$J,358.3,10262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10262,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,10262,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,10262,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,10263,0)
 ;;=070.51^^67^673^29
 ;;^UTILITY(U,$J,358.3,10263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10263,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,10263,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,10263,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,10264,0)
 ;;=070.54^^67^673^30
 ;;^UTILITY(U,$J,358.3,10264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10264,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,10264,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,10264,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,10265,0)
 ;;=571.41^^67^673^32
 ;;^UTILITY(U,$J,358.3,10265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10265,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,10265,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,10265,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,10266,0)
 ;;=571.1^^67^673^33
 ;;^UTILITY(U,$J,358.3,10266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10266,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,10266,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,10266,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,10267,0)
 ;;=070.59^^67^673^34
 ;;^UTILITY(U,$J,358.3,10267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10267,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,10267,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,10267,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,10268,0)
 ;;=V08.^^67^673^24
 ;;^UTILITY(U,$J,358.3,10268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10268,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,10268,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,10268,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,10269,0)
 ;;=042.^^67^673^25
 ;;^UTILITY(U,$J,358.3,10269,1,0)
 ;;=^358.31IA^5^2
